Skip to main content

AMERIPRISE FINANCIAL INC

Position in AVXL — Anavex Life Sciences Corp.

CIK 820027 MINNEAPOLIS, MN

Position in AVXL

as of Mar 31, 2026 · filed Jul 17, 2026
Position Value
$228,324
-$15,624 QoQ
Shares Held
74,373
+8.5% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 15% None 85%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

AMERIPRISE FINANCIAL INC holds $4,254,627,646 across 191 Biotechnology names. AVXL ranks #175 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVXL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $228,324 74,373
2025-12-31 $243,948 68,525
2025-09-30 $763,575 85,795
2025-06-30 $792,827 85,990
2025-03-31 $727,214 84,757
2024-12-31 $717,538 66,810
2024-09-30 $361,060 63,567
2024-06-30 $267,894 63,482
2024-03-31 $326,839 64,212
2023-12-31 $508,809 54,652
2023-09-30 $238,256 36,375
2023-06-30 $272,037 33,461
2023-03-31 $286,888 33,476
2022-12-31 $311,598 33,650
2022-09-30 $203,871 19,755
2022-06-30 $174,223 17,405
2022-03-31 $210,562 17,105
2021-12-31 $398,212 22,965
2021-09-30 $645,571 35,965
2021-06-30 $1,420,977 62,160
2021-03-31 $1,392,218 93,125
2020-12-31 $369,360 68,400
2020-09-30 $149,034 32,755
2020-06-30 $74,144 15,070
2020-03-31 $52,935 16,805